Calidi announces reverse stock split, expected to begin trading on a 1-for-12 split adjusted basis

14 hours ago 1

Calidi Biotherapeutics (NYSE:CLDI) said on Friday that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12.
The company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025, under the existing symbol of “CLDI.”
Calidi (NYSE:CLDI) shares were down more than 10% in extended trading.

Recommended For You